H.R. 6833 · 117th Congress
Insulin $35 cap
Affordable Insulin Now Act
What it does
Caps out-of-pocket insulin costs at $35 a month in private insurance and Medicare.
Outcome
Passed the House on March 31, 2022 and stalled in the Senate. A Medicare-only cap later became law in the Inflation Reduction Act. The bill number was later reused as a spending vehicle, so only the March 2022 vote is counted.
The test
| Pillar | Question | Answer | Why |
|---|---|---|---|
| Economy | Who lobbied for it, and who against? | Helps Americans | Insurer group AHIP and PBM trade groups opposed the cap; diabetes patient groups supported it. |
| Everyday life | Does it lower or raise what Americans pay directly? | Helps Americans | Direct cap on what patients pay at the pharmacy. |
| Consensus | Where reliable polling exists, do most Americans across parties support or oppose it? | Helps Americans | Large majorities in every party support capping insulin costs (KFF Health Tracking Poll, 2022). |
Votes counted: House 232–193 on Mar 31, 2022.